$CMMB Some DD: This is a pretty sweet deal considering big pharma have been on a spending spree lately to fund Phase 3 trials.
$5 per ADS owned BEFORE merger closes for Chemomab shareholders IF Scipher/Chemomab initiate Phase 3 for PSC. And they included a wording in the 6-K
